There have been 18 further Coronavirus-related deaths and 349 new cases according to figures released by the health authorities this evening.
17 deaths occurred in March, and 1 in February.
The median age of those who died was 78 years and the age range was 55 – 102 years.
Of today’s cases four of them are in Laois, meaning the county’s 14-day incidence rate increases slightly to 86.2.
Of the cases notified today:
- 172 are men / 177 are women
- 70% are under 45 years of age
- The median age is 33 years old
- 156 in Dublin, 23 in Meath, 19 in Donegal, 15 in Louth, 14 in Kildare and the remaining 122 cases are spread across all other counties.
As of 8am today, 355 COVID-19 patients are hospitalised, of which 88 are in ICU. 36 additional hospitalisations in the past 24 hours.
As of March 13th, 615,934 doses of COVID-19 vaccine have been administered in Ireland:
- 451,589 people have received their first dose
- 164,345 people have received their second dose
The COVID-19 Dashboard provides up-to-date information on the key indicators of COVID-19 in the community including daily data on Ireland’s COVID-19 Vaccination Programme.
New Cases in Laois
- March 15 – 4
- March 14 – 2
- March 13 – 5
- March 12 – 3
- March 11 – 2
- March 10 – 8
- March 9 – 3
- March 8 – 1
- March 7 – 5
- March 6 – 8
- March 5 – 5
- March 4 – 10
- March 3 – 4
- March 2 – 11
- March 1 – 1
14-day case rate in Laois per 100,000 population
- March 15 – 86.2
- March 14 – 81.5
- March 13 – 93.3
- March 12 – 103.9
- March 11 – 118.1
- March 10 – 133.4
- March 9 – 135.8
- March 8 – 157
- March 7 – 168.8
- March 6 – 177.1
- March 5 – 183
- March 4 – 211.3
- March 3 – 213.7
- March 2 – 231.4
- March 1 – 247.9
New cases in Laois during past 14 days
- March 15 – 73
- March 14 – 69
- March 13 – 79
- March 12 – 88
- March 11 – 100
- March 10 – 113
- March 9 – 115
- March 8 – 133
- March 7 – 143
- March 6 – 150
- March 5 – 155
- March 4 – 179
- March 3 – 181
- March 2 – 196
- March 1 – 210
EU Regulator says ‘No indication’ AstraZeneca caused blood clots
The EU’s drug regulator has said it remained “firmly convinced” of the benefits of AstraZeneca’s coronavirus vaccine, despite several countries suspending its use over blood clot fears.
“We are still firmly convinced that the benefits of the AstraZeneca vaccine in preventing Covid-19 with its associated risk of hospitalisation and death outweigh the risk of these side effects,” European Medicines Agency chief Emer Cooke told an online press conference.
“At present there is no indication that vaccination has caused these conditions. They have not come up in the clinical trials and they are not listed as known or expected side effects,” Ms Cooke added.
